ReviewHaematologica2022

Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.

Lijie Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.